Product Categories
Country: | China |
---|---|
Tel: | +86-13347807150 |
Mobile: | +86-13347807150 |
E-mail: | support@tgpeptide.com |
QQ: | 511774137 |
Skype: | Chat Now! |
Address: | Room 1204, Building F, No. 22 Tiansheng Road, Jiangbei New Area, Nanjing |
Nanjing TGpeptide Biotechnology Co.,Ltd.("TGpeptide" hereafter), who is founded in 2019, located at Jiangbei New Material Industrial Park, is a professional enterprise enageged in researching, developing, manufacturing and sales of peptide, antibody and protein products and their technologies. TGpeptide got strong support and funded by government from the beginning when TGpeptide was founded. Dr. Wu, the founder and director of TGpeptide, was graduated from Georgia State University at 2011. Dr Wu engaged in peptide industrial research since he came back to China at 2012. Dr. Wu gained many honors during the research these years including "Progress Awards for Peptide Research and Bulk Manufacturing II", "Scarce Talent of Lanzhou" at 2013 etc.
|
Product Name | MF | CAS | Details |
---|
Substance P (6-11) | C36H52N8O7S | 51165-07-2 | Details |
(Arg6,D-Trp7.9,N-Me-Phe8)-Substance P (6-11) | C49H66N12O6S | 115150-59-9 | Details |
(Pyr6,Pro9)-Substance P (6-11) | C39H53N7O7S | 79775-19-2 | Details |
Succinyl-(Asp6,N-Me-Phe8)-Substance P (6-11) | C40H55N7O11S | 106128-89-6 | Details |
Substance P (7-11) | C31H44N6O5S | 51165-05-0 | Details |
Substance P (9-11) | C13H27ClN4O3S | 40297-96-9 | Details |
[D-Trp7,9,10]-Substance P | C79H105N21O13S | 89430-38-6 | Details |
[D-Trp34]-Neuropeptide Y | C196H289N55O56 | 153549-84-9 | Details |
Acetyl-PHF6 amide | C38H63N9O9 | 878663-43-5 | Details |
Acetyl-PHF4 amide | C28H46N6O6 | 2022956-50-7 | Details |
Acetyl-PHF5 amide | C33H54N8O8 | 1190970-24-1 | Details |
Acetyl-PHF6IV amide | C37H61N9O9 | 2022956-51-8 | Details |
Acetyl-PHF6KE amide | C37H58N8O11 | 1079892-79-7 | Details |
Acetyl-PHF6QV amide | C38H64N8O8 | 2022956-52-9 | Details |
Acetyl-PHF6YA amide | C32H59N9O8 | 885610-34-4 | Details |
Ac-Tyr-Lys-NH2 | C17H26N4O4 | 270597-64-3 | Details |
Ac-Val-Tyr-Lys-NH2 | C22H35N5O5 | 884009-99-8 | Details |
Microtubule-Associated Protein (142-161) (human) | C86H147N23O31 | 565227-74-9 | Details |
PHF6 | C36H60N8O9 | 329897-62-3 | Details |
Tau Peptide (1-16) (human) | C77H120N20O28S3 | 2022956-53-0 | Details |
Substance P | C63H98N18O13S | 33507-63-0 | Details |
Tau Peptide (273-284) | C62H113N17O17 | 1663490-91-2 | Details |
Tau Peptide (45-73) (Exon 2/Insert 1 Domain) | C120H189N31O57 | 2022956-54-1 | Details |
Tau Peptide (74-102) (Exon 3/Insert 2 Domain) | C124H198N34O46 | 1322695-34-0 | Details |
(Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) | C81H133N29O36P2 | 2022956-55-2 | Details |
(Thr(PO3H2)231)-Tau Peptide (225-237) | C61H109N18O20P | 1670270-09-3 | Details |
Tau Peptide (244-274) (Repeat 1 Domain) | C141H238N42O44S | 330456-24-1 | Details |
Acetyl-Tau Peptide (244-274) (Repeat 1 Domain) | C143H240N42O45S | 2022956-56-3 | Details |
Tau Peptide (245-274) (Repeat 1 Domain) | C136H230N40O42S | 1428134-39-7 | Details |
Tau Peptide (255-314) (Repeat 2 Domain) (human) | 2022995-68-0 | Details |
(Ser(PO3H2)262)-Tau Peptide (260-264) PAb Blocking | C20H36N5O13P | 2022956-57-4 | Details |
Tau Peptide (268-282) | C72H125N23O19 | 330456-37-6 | Details |
Acetyl-Tau Peptide (273-284) amide | C64H116N18O17 | 1684399-52-7 | Details |
BIM-23042 | C63H73N11O9S2 | 111857-96-6 | Details |
(D-Phe5,Cys6.11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide | C50H67N11O10S2 | 340821-13-8 | Details |
Somatostatin-14 (7-14) | C49H66N10O12S | 331627-76-0 | Details |
(D-Phe7)-Somatostatin-14 | C76H104N18O19S2 | 64813-74-7 | Details |
(D-Trp8)-Somatostatin-14 | C76H104N18O19S2 | 58976-46-8 | Details |
Tyr-Somatostatin-14 | C85H113N19O21S2 | 58100-03-1 | Details |
(Tyr1)-Somatostatin-14 | C82H108N18O20S2 | 59481-23-1 | Details |
(Tyr11)-Somatostatin-14 | C76H104N18O20S2 | 59481-27-5 | Details |
Somatostatin-25 | C127H191N37O34S3 | 76461-17-1 | Details |
Somatostatin-28 | C137H207N41O39S3 | 73032-94-7 | Details |
(Leu8,D-Trp22,Tyr25)-Somatostatin-28 | C138H209N41O40S2 | 77909-99-0 | Details |
Biotinyl-(Leu8,D-Trp22,Tyr25)-Somatostatin-28 | C148H223N43O42S3 | 143519-58-8 | Details |
Tyr-Somatostatin-28 | C146H216N42O41S3 | 86649-84-5 | Details |
Somatostatin-28 (1-12) | C49H81N17O19S | 81286-16-0 | Details |
Somatostatin-28 (1-14) | C61H105N23O21S | 79243-10-0 | Details |
H-Tyr-Cys-Phe-Ala-Trp-Lys-Thr-Phe-Cys-OH (Disulfide bond) | C57H71N11O12S2 | 647016-22-6 | Details |
Vapreotide | C57H70N12O9S2 | 103222-11-3 | Details |
Stresscopin (human) | C195H326N56O53S2 | 352020-03-2 | Details |
(Tyr0)-Stresscopin (human) | 1816939-43-1 | Details |
Stresscopin-Related Peptide (human) | C205H358N68O57 | 348626-74-4 | Details |
Urocortin (human) | C206H338F3N63O66 | 176591-49-4 | Details |
Urocortin (rat) | C206H338N62O64 | 171543-83-2 | Details |
(Tyr0)-Urocortin (rat) | 187111-93-9 | Details |
Urocortin II (human) | C196H340F3N63O56S | 398001-88-2 | Details |
Urocortin II (mouse) | 330648-32-3 | Details |
Urocortin III (human) | C185H307N53O50S2 | 357952-09-1 | Details |
Urocortin III (mouse) | C186H312N52O52S2 | 357952-10-4 | Details |
Tau Peptide (274-288) | C77H138N22O23 | 330456-39-8 | Details |
Tau Peptide (275-305) (Repeat 2 Domain) | C139H239N43O45S | 330456-25-2 | Details |
Tau Peptide (277-291) | C73H131N21O23S | 330456-40-1 | Details |
Tau Peptide (294-305) (human) | C51H85N17O17 | 1428135-29-8 | Details |
Tau Peptide (295-309) | C66H110N20O21 | 330456-46-7 | Details |
Tau Peptide (298-312) | C72H116N20O19 | 330456-47-8 | Details |
Tau Peptide (301-315) | C70H113N17O21 | 330456-48-9 | Details |
Tau Peptide (304-318) | C75H126N18O22 | 330456-49-0 | Details |
Tau Peptide (306-317) | C65H109N15O18 | 1003007-59-7 | Details |
Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) | C153H250N44O44S2 | 2022956-58-5 | Details |
Tau Peptide (306-336) (Repeat 3 Domain) | C143H236N42O42S | 330456-26-3 | Details |
(Pyr5,N-Me-Phe8,Sar9)-Substance P (5-11) | C43H61N9O9S | 77128-69-9 | Details |
Biotinyl-Substance P | C73H112N20O15S2 | 87468-58-4 | Details |
Substance P (free acid) | C63H97N17O14S | 71977-09-8 | Details |
Substance P-methyl ester | C64H99N17O14S | 76260-78-1 | Details |
(D-Arg1,D-Pro2,D-Trp7.9,Leu11)-Substance P | C75H108N20O13 | 84676-91-5 | Details |
(D-Arg1,D-Trp5.7.9,Leu11)-Substance P | C81H110N20O12 | 122481-75-8 | Details |
Spantide I | C75H108N20O13 | 91224-37-2 | Details |
Spantide II | C86H104Cl2N18O13 | 129176-97-2 | Details |
(D-Pro2,D-Trp7.9)-Substance P | C74H106N20O13S | 80434-86-2 | Details |
(Sar9,Met(O2)11)-Substance P | C64H100N18O15S | 110880-55-2 | Details |
(Tyr8)-Substance P | C63H98N18O14S | 55614-10-3 | Details |
Substance P (1-7) | C41H65N13O10 | 68060-49-1 | Details |
Substance P (1-9) | C52H77N15O12 | 57468-17-4 | Details |
Substance P (2-11) | C57H86N14O12S | 53749-61-4 | Details |
Substance P (4-11) | C46H67N11O10S | 53749-60-3 | Details |
(D-Pro4,D-Trp7.9.10)-Substance P (4-11) | C62H74N14O10S | 86917-57-9 | Details |
(D-Pro4,D-Trp7.9.10,Val8)-Substance P (4-11) | C58H74N14O10S | 86917-56-8 | Details |
Substance P (5-11) | C41H60N10O9S | 51165-09-4 | Details |
Tau Peptide (307-321) | C78H133N19O23 | 330456-50-3 | Details |
Tau Peptide (323-335) | C60H103N21O20 | 2022956-59-6 | Details |
Tau Peptide (337-368) (Repeat 4 Domain) | C150H248N44O50 | 330456-27-4 | Details |
Tau Peptide (379-408) | C140H228N44O46 | 1246357-53-8 | Details |
(Ser(PO3H2)396.404)-Tau Peptide (379-408) | C140H230N44O52P2 | 2022956-60-9 | Details |
Lys-Trp-Lys-(Ser(GlcNAc-β-D)400)-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide | 2022974-40-7 | Details |
Tau Peptide (472-487)-PEG6-(507-526) (human) | 2243219-84-1 | Details |
H-Leu-Ser-Lys-Leu-OH | C21H41N5O6 | 162559-45-7 | Details |
T-Peptide | C92H171N45O18 | 2022956-62-1 | Details |
Tau Peptide (512-525) amide | C51H77N15O21 | 2022956-61-0 | Details |
H-Leu-Ser-Ala-Leu-OH | C18H34N4O6 | 169249-03-0 | Details |
Product Total: Product Page: | ||||
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 |